quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:57:00·43d
PRRelease
BIO-key International Inc. logo
TD SYNNEX Corporation logo

BIO-key Partners with TD SYNNEX Public Sector (DLT) to Deliver Identity-Bound Biometric and IAM Solutions to the U.S. Public Sector

BKYI· BIO-key International Inc.SNX· TD SYNNEX Corporation
Technology
Original source

Companies

  • BKYI
    BIO-key International Inc.
    Technology
  • SNX
    TD SYNNEX Corporation
    Technology

Recent analyst ratings

  • Jan 13SNXUpdateGoldman$180.00
  • Jun 11SNXUpdateMorgan Stanley$145.00
  • Mar 20SNXUpdateBarrington Research$156.00
  • Jul 15SNXUpdateRBC Capital Mkts$140.00
  • Apr 16SNXUpdateUBS$145.00
  • Jan 8SNXUpdateJP Morgan$113.00

Related

  • SEC1d
    BIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing
  • PR2d
    TD SYNNEX Wins 2026 Google Cloud Distribution: Market Reach Partner of the Year Award
  • PR3d
    Opensense Announces Partnership with TD SYNNEX, Bringing Centralized Email Signature Management to the MSP Channel
  • SEC4d
    BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • INSIDER6d
    SEC Form 4 filed by Polk Dennis
  • INSIDER7d
    SEC Form 4 filed by Vezina Ann F
  • INSIDER7d
    SEC Form 4 filed by Saintil Merline
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022